Patient Management

2074 questions

Question 1901Question →

A 62-year-old man is brought to the emergency department with sudden-onset, severe, "tearing" chest pain that radiates to his interscapular region. His blood pressure is 210/115 mm Hg, and his heart rate is 118/min. A bedside transesophageal echocardiogram demonstrates an intimal flap in the descending aorta. The clinical team prepares to initiate aggressive medical management prior to definitive vascular surgery evaluation. Arrange the following pharmacologic interventions in the most appropriate sequential order for managing this patient's acute presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order is: 1) Intravenous morphine, 2) Intravenous esmolol, and 3) Intravenous sodium nitroprusside.
The correct sequence for managing an acute aortic dissection prioritizes decreasing sympathetic tone and aortic wall shear stress (dP/dt) before aggressively lowering blood pressure. First, adequate analgesia (intravenous morphine) is provided to mitigate pain-induced sympathetic activation. Second, an intravenous beta-blocker (esmolol) is administered to lower the heart rate and decrease left ventricular contractility. Finally, an intravenous vasodilator (sodium nitroprusside) is administered to lower the systolic blood pressure. Initiating the vasodilator before the beta-blocker is strongly contraindicated as it causes reflex tachycardia, thereby increasing aortic shear stress and the risk of dissection propagation.

Step-by-Step Solution

1
Control pain with intravenous opioids.
Decreased sympathetic nervous system output.
Severe pain drives tachycardia and hypertension; initial analgesia lowers basal catecholamine levels.
2
Administer an intravenous beta-blocker.
Decreased heart rate (target < 60/min) and decreased left ventricular contractility.
Lowering the rate of rise of ventricular pressure (dP/dt) minimizes shear stress on the aortic wall and prevents extension of the intimal tear.
3
Initiate an intravenous vasodilator.
Decreased systolic blood pressure to a target of 100-120 mm Hg.
Vasodilators are required to reach the blood pressure target but will cause dangerous reflex tachycardia and increased shear stress if administered prior to adequate beta-blockade.

Key Concept

In the acute pharmacologic management of aortic dissection, pain control is followed by heart rate control (beta-blockers) to decrease aortic shear stress, which must strictly precede blood pressure control (vasodilators) to prevent reflex tachycardia.
Question 1902Question →

A retired construction worker, aged 69, establishes care at a new primary care facility following his previous provider's relocation. He currently feels well, walks three miles daily, and denies any cardiopulmonary or gastrointestinal symptoms. He consumed two packs of cigarettes daily starting in high school but completely abstained from all tobacco products starting at age 52 after a friend developed emphysema. His records document a colonoscopy with no abnormal findings performed four years ago. His body mass index is 26 kg/m^2, and his blood pressure is 122/76 mmHg. He asks which cancer and vascular screening tests are indicated for him today. According to evidence-based recommendations, what is the most appropriate imaging or laboratory test to order?

Show answer & explanation

Answer: Ultrasonography of the abdominal aorta

Answer

Ultrasonography of the abdominal aorta
The correct recommendation is ultrasonography of the abdominal aorta. This is a Grade B USPSTF recommendation for men aged 65 to 75 years who have ever smoked (100 or more cigarettes in their lifetime). The goal is to detect asymptomatic aneurysms before life-threatening rupture occurs. Because this patient is 69 and smoked heavily in the past, he is a textbook candidate for this one-time screening.

Step-by-Step Solution

1
Assess the patient's age and biological sex to establish baseline preventive care milestones.
The patient is a 69-year-old male.
Age and sex determine eligibility for condition-specific screening programs like AAA and prostate cancer.
2
Analyze the patient's smoking history to determine eligibility for lung cancer and vascular screening.
He has a greater than 20 pack-year history but quit 17 years ago (at age 52). He qualifies as an 'ever smoker'.
Tobacco exposure is a key trigger for specific USPSTF recommendations, requiring precise calculations of pack-years and time since cessation.
3
Apply the USPSTF criteria for abdominal aortic aneurysm (AAA) screening.
Men aged 65-75 who have ever smoked require a one-time AAA screening with ultrasound. The patient meets these criteria.
AAA screening significantly reduces mortality in this specific demographic.
4
Apply the USPSTF criteria for lung cancer screening.
The patient does not qualify for low-dose CT screening because he quit smoking more than 15 years ago.
Guidelines explicitly stipulate discontinuing screening once 15 years have passed since complete smoking cessation.

Key Concept

A one-time screening for abdominal aortic aneurysm (AAA) with ultrasonography is indicated for men aged 65 to 75 years who have ever smoked, whereas lung cancer screening with low-dose CT must be discontinued if a patient has abstained from smoking for 15 years or more.
Question 1903Question →

A 45-year-old man visits his primary care provider due to worsening joint pain, generalized fatigue, and excessive sweating over the past three years. He mentions having to buy larger shoes and a new wedding band recently because his old ones no longer fit. His wife notes that his snoring has become exceptionally loud and he occasionally gasps for air during sleep. Vital signs show a blood pressure of 158/96 mmHg. Physical examination reveals a prominent brow ridge, a widened jaw, an enlarged tongue, and broad, fleshy hands. The physician suspects a specific hypersecretory endocrine disorder.

Arrange the following diagnostic steps in the most appropriate sequence to properly evaluate this patient's suspected condition, proceeding from the initial screening test to final anatomical localization.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence begins with measuring serum IGF-1 as the initial screen, followed by an oral glucose tolerance test with GH measurement for biochemical confirmation, and concluding with a pituitary MRI for anatomical localization.
The diagnostic workup for suspected acromegaly follows a strict, tiered, cost-effective algorithm. It begins with a highly sensitive initial screening test (IGF-1), which is followed by a highly specific confirmatory biochemical test (OGTT with GH measurement) if the initial screen is positive. Only after the disease is biochemically proven should the clinician proceed to anatomical localization (MRI of the pituitary) to plan surgical intervention.

Step-by-Step Solution

1
Order a serum insulin-like growth factor-1 (IGF-1) level.
Identifies if there is sustained, abnormal elevation of growth hormone.
Growth hormone is secreted in a pulsatile manner, making random GH levels unreliable. IGF-1 provides a steady, time-averaged surrogate marker for GH hypersecretion.
2
Perform an oral glucose tolerance test (OGTT) with GH suppression.
Confirms the diagnosis of acromegaly if GH levels fail to suppress below 1 ng/mL.
Hyperglycemia physiologically inhibits GH release. Autonomous production by a pituitary adenoma will not exhibit this normal physiological suppression, establishing definitive biochemical proof of the disease.
3
Obtain a magnetic resonance imaging (MRI) scan of the pituitary gland.
Localizes the pituitary adenoma.
Imaging is required to evaluate the size and extent of the adenoma for surgical planning, but it must be done last to ensure the mass seen is actually the source of hormone hypersecretion rather than a benign incidentaloma.

Key Concept

In the diagnostic workup of suspected acromegaly, biochemical testing must always precede anatomical imaging to avoid false-positive diagnoses caused by pituitary incidentalomas.
Estimated Time:1m 0s
Question 1904Question →

A 34-year-old woman is evaluated in the outpatient clinic for follow-up of a deep vein thrombosis (DVT). Three days ago, she presented to the emergency department with left leg swelling and was diagnosed with an unprovoked left popliteal DVT. She was discharged with a prescription for rivaroxaban. Her past medical history is significant for systemic lupus erythematosus (SLE) with polyarthritis, well-controlled on hydroxychloroquine. She also has a history of two consecutive spontaneous abortions at 10 and 12 weeks of gestation. Current medications are rivaroxaban and hydroxychloroquine. Vital signs are within normal limits. Physical examination shows mild left lower extremity pitting edema.

Laboratory studies obtained during the emergency department visit are reviewed:
Hemoglobin: 12.2 g/dL
Platelet count: 130,000/mm³
Prothrombin time (PT): 13 seconds (normal: 11-15 seconds)
Activated partial thromboplastin time (aPTT): 62 seconds (normal: 25-40 seconds)

A 1:1 mixing study with normal plasma yields an aPTT of 58 seconds.

Which of the following is the most appropriate pharmacologic intervention for this patient's deep vein thrombosis?

Show answer & explanation

Answer: Discontinue rivaroxaban and initiate enoxaparin bridged to warfarin

Answer

The most appropriate intervention is to discontinue rivaroxaban and initiate enoxaparin bridged to warfarin.
The correct intervention requires recognizing that this patient has Antiphospholipid Syndrome (APS), characterized by recurrent miscarriages, SLE, and a lupus anticoagulant (demonstrated by the uncorrected prolonged aPTT on a mixing study). For patients with APS who develop venous thromboembolism, direct oral anticoagulants (DOACs) like rivaroxaban are contraindicated due to a significantly higher risk of recurrent thromboembolic events compared to vitamin K antagonists. Therefore, the standard of care is to immediately discontinue the DOAC and initiate an overlapping bridge of low-molecular-weight heparin (e.g., enoxaparin) and warfarin until a therapeutic INR is achieved.

Step-by-Step Solution

1
Analyze the patient's history and lab findings to establish the underlying diagnosis.
The patient has SLE, recurrent mid-trimester miscarriages, and an isolated prolonged aPTT that fails to correct with a 1:1 mixing study.
Failure to correct on a mixing study indicates the presence of an inhibitor (in this case, lupus anticoagulant) rather than a factor deficiency. Combined with her clinical history, this confirms a diagnosis of Antiphospholipid Syndrome (APS).
2
Evaluate the current pharmacologic management for venous thromboembolism (VTE) in the context of the newly established diagnosis.
The patient is currently taking rivaroxaban, a direct oral anticoagulant (DOAC).
DOACs have been shown in randomized trials (e.g., TRAPS) to have unacceptably high rates of recurrent arterial and venous thrombosis in patients with APS compared to vitamin K antagonists.
3
Select the safest, guideline-concordant pharmacologic intervention.
Warfarin therapy is selected as the definitive treatment.
Because warfarin requires several days to achieve therapeutic anticoagulation, the patient must be bridged with a parenteral anticoagulant such as low-molecular-weight heparin (enoxaparin) until the INR is therapeutic.

Key Concept

Direct oral anticoagulants (DOACs) are contraindicated for the treatment of venous thromboembolism in patients with Antiphospholipid Syndrome (APS); these patients require treatment with low-molecular-weight heparin bridged to warfarin.

Alternative Method

When evaluating a prolonged aPTT, remembering the 'mixing study rule' rapidly narrows the differential: if it corrects, it is a factor deficiency (e.g., hemophilia); if it fails to correct, it is an inhibitor (e.g., lupus anticoagulant or specific factor inhibitor).
Estimated Time:1m 30s
Question 1905Question →

An oncology team evaluates a 59-year-old male with metastatic melanoma before administering his next scheduled dose of pembrolizumab. He reports feeling unusually anxious and sweaty over the past two weeks, along with experiencing mild hand tremors. He has no other medical history. Vital signs show a blood pressure of 135/82 mm Hg135/82 \text{ mm Hg} and a regular pulse of 110 /min110 \text{ /min}. Physical examination reveals a fine action tremor and warm, moist skin, but no focal abdominal or pulmonary findings. Laboratory results demonstrate a thyroid-stimulating hormone (TSH) level of <0.01μU/mL<0.01 \mu\text{U/mL} (normal: 0.5−5.0μU/mL0.5-5.0 \mu\text{U/mL}) and a free T4 of 2.8 ng/dL2.8 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL}). His hepatic and renal function panels are within normal limits. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Continue pembrolizumab and prescribe a beta-adrenergic antagonist

Answer

Continue pembrolizumab and prescribe a beta-adrenergic antagonist.
The patient is experiencing immune checkpoint inhibitor (ICI)-induced thyroiditis, a well-recognized endocrine immune-related adverse event (irAE) associated with PD-1 inhibitors like pembrolizumab. It typically presents as a painless, destructive thyroiditis with a transient thyrotoxic phase (suppressed TSH, elevated free T4) followed by permanent hypothyroidism. Unlike other organ-specific irAEs (e.g., pneumonitis, colitis, hepatitis) which often require prompt discontinuation of the ICI and initiation of high-dose systemic corticosteroids, endocrine irAEs are a notable exception. For Grade 1 or 2 ICI-induced hyperthyroidism, the standard of care is to continue the immunotherapy and manage hyperadrenergic symptoms with a beta-adrenergic antagonist (e.g., propranolol). Patients must be monitored closely with serial thyroid function tests, as the transition to hypothyroidism often occurs within weeks and subsequently requires lifelong levothyroxine supplementation.

Step-by-Step Solution

1
Interpret the clinical and laboratory presentation.
The patient has thyrotoxicosis (suppressed TSH, elevated free T4) with symptomatic tachycardia and tremor developing shortly after starting pembrolizumab.
Establishing the etiology of thyrotoxicosis is essential for determining the safest and most effective management strategy.
2
Identify the underlying mechanism of the adverse event.
Pembrolizumab, an immune checkpoint inhibitor, frequently causes immune-related adverse events (irAEs), including destructive thyroiditis characterized by a transient release of preformed thyroid hormone.
Recognizing this as destructive thyroiditis rather than increased hormone synthesis (e.g., Graves disease) dictates the correct pharmacologic approach.
3
Select the appropriate treatment modification and monitoring strategy.
Systemic corticosteroids and immunotherapy suspension are not required. Beta-blockers should be initiated for symptom control while the cancer therapy continues.
Endocrine irAEs uniquely do not require immunosuppression, allowing life-saving cancer therapy to continue uninterrupted while symptoms are managed.

Key Concept

Immune checkpoint inhibitor-induced thyroiditis typically presents with a transient thyrotoxic phase that should be managed with symptom control (e.g., beta-blockers) while continuing the immunotherapy. It does not require systemic corticosteroids or treatment discontinuation.
Question 1906Question →

A 54-year-old male patient presents to his primary care provider for an annual wellness visit. His medical history is notable for type 2 diabetes mellitus, which is currently well-controlled on metformin monotherapy. He has a remote smoking history, having consumed 1 pack of cigarettes daily for 25 years before successfully quitting 18 years ago. His last comprehensive physical examination was five years ago. He is up to date on colorectal cancer screening, having undergone a normal colonoscopy two years ago. He received a tetanus-diphtheria (Td) booster 2 years ago following a minor hand laceration. He has no prior history of receiving pneumococcal, zoster, or human papillomavirus (HPV) vaccines. Which of the following preventive interventions are indicated for this patient at today's visit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Administration of the 20-valent pneumococcal conjugate vaccine; Administration of the recombinant zoster vaccine

Answer

The correct interventions are administration of the 20-valent pneumococcal conjugate vaccine and administration of the recombinant zoster vaccine.
The correct interventions for this patient include the 20-valent pneumococcal conjugate vaccine and the recombinant zoster vaccine. Pneumococcal vaccination is indicated for adults aged 19 to 64 years with certain underlying medical conditions, such as diabetes mellitus. Furthermore, the recombinant zoster vaccine is routinely recommended as a two-dose series for all adults aged 50 years and older to prevent herpes zoster.

Step-by-Step Solution

1
Evaluate the patient's age and vaccination history for age-based immunizations.
The patient is 54 years old and has never received the recombinant zoster vaccine.
The recombinant zoster vaccine is indicated for all immunocompetent adults aged 50 years and older to prevent herpes zoster and postherpetic neuralgia.
2
Assess the patient's medical comorbidities to determine risk-based vaccine indications.
The patient has type 2 diabetes mellitus and has no prior history of pneumococcal vaccination.
Adults aged 19-64 with specific underlying medical conditions (including diabetes) require pneumococcal vaccination (e.g., PCV20).
3
Analyze the patient's smoking history and age against cancer and vascular screening guidelines.
The patient is 54 years old and has a 25 pack-year smoking history, but he successfully quit 18 years ago.
Lung cancer screening is not indicated because the patient quit smoking more than 15 years ago. Abdominal aortic aneurysm screening is not indicated because the patient is under 65 years of age.

Key Concept

Application of USPSTF and ACIP guidelines for preventive screening and adult immunizations based on age, medical comorbidities, and detailed social history.
Question 1907Question →

Emergency medical services arrive at the trauma center with a 29-year-old man who sustained a stab wound during a physical altercation. The patient is awake but extremely agitated, frequently grasping at his throat. His blood pressure is 90/50 mm Hg, heart rate is 124/min, respiratory rate is 26/min, and oxygen saturation is 92% on a non-rebreather mask. Physical examination reveals a 3-cm linear laceration in the right anterior neck, located in the area between the cricoid cartilage and the angle of the mandible. There is a rapidly enlarging, pulsatile hematoma deep to the laceration. The patient's voice is muffled, he exhibits audible biphasic stridor, and copious bloody secretions are pooling in his oropharynx. Which of the following are the most appropriate immediate procedural and surgical interventions for this patient? (Select all that apply.)

Select all that apply

Show answer & explanation

Answer: Establishment of a definitive airway via endotracheal intubation or surgical cricothyroidotomy; Emergent transfer to the operating room for neck exploration

Answer

The correct interventions are the immediate establishment of a definitive airway and emergent transfer to the operating room for neck exploration.
This patient presents with multiple 'hard signs' of penetrating neck trauma: an expanding pulsatile hematoma, hemodynamic instability (blood pressure 90/50 mm Hg), stridor, and a muffled voice. The presence of any hard sign mandates two immediate actions: securing the airway and emergent surgical exploration. Stridor and pooling bloody secretions indicate an impending airway catastrophe, making the establishment of a definitive airway (via endotracheal intubation or a surgical cricothyroidotomy if the upper airway is obscured) the absolute top priority. Once the airway is secured, the rapidly expanding hematoma and shock require immediate transfer to the operating room to surgically identify and repair the underlying vascular and aerodigestive injuries.

Step-by-Step Solution

1
Assess the patient's hemodynamic stability and identify 'hard signs' of penetrating neck trauma.
The patient has an expanding pulsatile hematoma, stridor, muffled voice, and hemodynamic instability (hypotension, tachycardia).
Hard signs differentiate patients who need immediate surgical intervention from those who can undergo diagnostic imaging.
2
Determine the immediate procedural priority regarding the ABCs (Airway, Breathing, Circulation).
The patient requires immediate securement of the airway via intubation or a surgical airway.
Stridor, muffled voice, and blood in the oropharynx signal an impending airway catastrophe that supersedes all other interventions.
3
Determine the definitive surgical management strategy based on the physical findings.
The patient must be transferred directly to the operating room for emergent exploration.
Patients with hard signs of vascular or aerodigestive injury in penetrating neck trauma require immediate surgical hemostasis, not imaging or observation.

Key Concept

Patients with penetrating neck trauma presenting with 'hard signs' (e.g., airway compromise, expanding/pulsatile hematoma, active hemorrhage, shock, or neurologic deficit) require immediate establishment of a definitive airway followed by emergent surgical exploration.
Estimated Time:1m 30s
Question 1908Question →

Evaluate the following emergency department patient presentations. Match each clinical scenario to the most appropriate initial disposition and care setting based on current clinical guidelines and risk stratification scores.

Click a left item, then click its matching right item

Items

A 55-year-old patient with community-acquired pneumonia presenting with acute disorientation, a respiratory rate of 34/min, and a blood pressure of 85/50 mmHg.
A 49-year-old patient with intermittent chest discomfort, non-diagnostic electrocardiogram findings, negative serial high-sensitivity troponins, and a calculated HEART score of 1.
A 64-year-old patient with an acute pulmonary embolism who is normotensive but demonstrates right ventricular hypokinesis on echocardiography and elevated cardiac biomarkers.
A 35-year-old patient with acute pyelonephritis, temperature of 39.1°C (102.4°F), and intractable nausea preventing tolerance of oral medications, with stable hemodynamics.

Matches

Show answer & explanation

Answer

The severe pneumonia patient requires the ICU; the low-risk chest pain patient should be discharged Home; the submassive pulmonary embolism patient requires the Intermediate Care/Telemetry Unit; and the pyelonephritis patient requires the General Medical Floor.
Appropriate disposition relies on matching a patient's risk of clinical deterioration and necessary therapeutic interventions with the capabilities of the care setting. The intensive care unit is reserved for those with or at high risk for organ failure (e.g., severe pneumonia). Step-down units are for high-risk stable patients requiring close monitoring (e.g., submassive PE). The general floor is for stable patients requiring inpatient resources (e.g., IV medications for pyelonephritis). Safe discharges are indicated when validated tools (e.g., HEART score) demonstrate a very low risk of adverse events.

Step-by-Step Solution

1
Evaluate the severity of the community-acquired pneumonia presentation.
The patient demonstrates confusion, severe tachypnea, and hypotension.
These signs indicate a high risk of respiratory or hemodynamic failure, meeting criteria for intensive care admission.
2
Risk-stratify the chest pain patient using the HEART score.
A score of 1 confirms a very low probability of a major adverse cardiac event.
Low-risk patients do not require inpatient admission or observation and can safely follow up as an outpatient.
3
Assess the risk level of the pulmonary embolism.
The presence of normal blood pressure with right ventricular strain and elevated biomarkers defines a submassive PE.
Submassive PE carries a significant risk of rapid clinical deterioration, warranting continuous monitoring typically available in an intermediate care setting.
4
Determine the resource needs for the pyelonephritis patient.
The patient is hemodynamically stable but requires intravenous administration of medications due to intractable vomiting.
The general medical floor provides appropriate nursing care for intravenous therapies in stable patients without organ dysfunction.

Key Concept

Risk stratification and appropriate care setting disposition using objective severity scores
Question 1909Question →

While climbing a flight of stairs at a shopping mall, a 7272-year-old man experiences a sudden loss of consciousness. Bystanders report that he collapsed without warning but regained full orientation within a minute of falling. He arrives at the emergency department via private vehicle thirty minutes later. His past medical history is significant for essential hypertension and hyperlipidemia. Current medications include lisinopril and atorvastatin. On arrival, he is asymptomatic and alert. Vital signs show a temperature of 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure of 138/82 mmHg138/82\text{ mmHg}, heart rate of 78/min78\text{/min}, and respiratory rate of 14/min14\text{/min}. Physical examination reveals a late-peaking, harsh systolic murmur heard best at the right second intercostal space with radiation to the neck. The lungs are clear to auscultation. A 12-lead electrocardiogram demonstrates voltage criteria for left ventricular hypertrophy and normal sinus rhythm with no ST-segment or T-wave abnormalities. Which of the following is the most appropriate next diagnostic study for this patient?

Show answer & explanation

Answer: Transthoracic echocardiography

Answer

Transthoracic echocardiography
Transthoracic echocardiography is the most appropriate next diagnostic study. The patient's presentation of exertional syncope coupled with a late-peaking, harsh systolic murmur radiating to the neck and left ventricular hypertrophy on ECG is highly suspicious for symptomatic, severe aortic stenosis. Exertion causes peripheral vasodilation to increase blood flow to muscles, but the critically stenotic aortic valve prevents a compensatory increase in cardiac output. This mismatch leads to acute cerebral hypoperfusion and subsequent syncope. Echocardiography is the gold standard initial test to visualize the valve, measure the transvalvular gradient, and assess left ventricular function.

Step-by-Step Solution

1
Analyze the clinical presentation of syncope.
The patient experienced exertional syncope with a rapid and complete recovery.
Exertional syncope points strongly toward a structural cardiac abnormality (like outflow obstruction) rather than a vasovagal or primary neurologic cause.
2
Correlate history with physical examination and electrocardiogram findings.
The physical exam reveals a late-peaking systolic murmur radiating to the neck, and the ECG shows left ventricular hypertrophy.
These findings are classic for severe aortic stenosis, which causes a fixed cardiac output leading to cerebral hypoperfusion during exertion.
3
Select the safest, most definitive initial diagnostic test based on the suspected etiology.
Transthoracic echocardiography is selected to confirm the diagnosis.
Echocardiography provides non-invasive, definitive assessment of valve morphology, transvalvular pressure gradients, and ventricular function without exposing the patient to the risks of exertion.

Key Concept

Patients presenting with exertional syncope and a characteristic late-peaking systolic murmur radiating to the carotids require prompt transthoracic echocardiography to evaluate for severe aortic stenosis. Provocative testing like exercise stress testing is strictly contraindicated.
Estimated Time:1m 0s
Question 1910Question →

Paramedics arrive at the emergency department with a 6666-year-old female patient who developed acute confusion, fever, and right-sided abdominal pain over the last 2424 hours. Her medical history includes an aortic valve replacement with a mechanical prosthesis requiring chronic warfarin therapy, as well as an episode of penicillin-induced anaphylaxis requiring mechanical ventilation 1010 years ago.

Vital signs on arrival are:
Temperature: 39.4∘C39.4^{\circ}\text{C} (102.9∘F102.9^{\circ}\text{F})
Blood pressure: 82/50 mmHg82/50\text{ mmHg}
Heart rate: 118 /min118\text{ /min}
Respiratory rate: 22 /min22\text{ /min}
Oxygen saturation: 95%95\% on room air

Physical assessment shows marked scleral icterus, a crisp mechanical heart click, and severe tenderness with voluntary guarding in the right upper abdominal quadrant.

Initial laboratory panel:
Leukocyte count: 18,500 /mm318,500\text{ /mm}^{3}
Total bilirubin: 4.5 mg/dL4.5\text{ mg/dL}
Alkaline phosphatase: 380 U/L380\text{ U/L}
Aspartate aminotransferase (AST): 145 U/L145\text{ U/L}
Alanine aminotransferase (ALT): 160 U/L160\text{ U/L}
Lactate: 4.8 mmol/L4.8\text{ mmol/L}
International Normalized Ratio (INR): 2.62.6 (patient's therapeutic target is 2.52.5 to 3.53.5)

Abdominal ultrasound demonstrates a 1.2 cm1.2\text{ cm} radiopaque stone in the common bile duct with proximal biliary dilation. Two sets of peripheral blood cultures are obtained. The clinical team diagnoses acute ascending cholangitis with resultant septic shock.

Which of the following pharmacologic interventions are appropriate for this patient's immediate management? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Administer intravenous fluid resuscitation with 30 mL/kg30\text{ mL/kg} of balanced crystalloids; Initiate empiric antimicrobial therapy with intravenous ciprofloxacin and metronidazole; Initiate intravenous norepinephrine if mean arterial pressure remains below 65 mmHg65\text{ mmHg} after fluid administration

Answer

The appropriate interventions are administering intravenous fluid resuscitation with 30 mL/kg30\text{ mL/kg} of balanced crystalloids, initiating empiric antimicrobial therapy with intravenous ciprofloxacin and metronidazole, and initiating intravenous norepinephrine if the mean arterial pressure remains below 65 mmHg65\text{ mmHg} after fluid administration.
The patient is in septic shock secondary to acute ascending cholangitis, a life-threatening emergency. Immediate management requires aggressive hemodynamic stabilization beginning with intravenous fluid resuscitation using 30 mL/kg30\text{ mL/kg} of balanced crystalloids. If the mean arterial pressure remains below 65 mmHg65\text{ mmHg} despite adequate fluid loading, a vasopressor (norepinephrine is the first-line agent) must be initiated to maintain vital organ perfusion. Concurrently, empiric broad-spectrum antibiotics targeting enteric Gram-negative organisms and anaerobes must be administered promptly. While piperacillin-tazobactam is a standard first-line choice for ascending cholangitis, this patient has a documented history of penicillin-induced anaphylaxis (an IgE-mediated reaction requiring intubation). Therefore, a non-beta-lactam regimen such as ciprofloxacin (providing Gram-negative coverage) and metronidazole (providing anaerobic coverage) is the appropriate guideline-concordant alternative.

Step-by-Step Solution

1
Evaluate the patient's hemodynamic status and primary diagnosis.
The patient is in septic shock (hypotension, tachycardia, elevated lactate) secondary to acute ascending cholangitis.
Identifying the immediate life-threatening condition dictates the required protocolized resuscitation steps.
2
Determine the appropriate initial hemodynamic interventions.
Administration of 30 mL/kg30\text{ mL/kg} of balanced crystalloids, followed by norepinephrine if the mean arterial pressure remains below 65 mmHg65\text{ mmHg}.
This is the standard of care for septic shock per Surviving Sepsis Campaign guidelines to restore adequate tissue perfusion.
3
Select an appropriate empiric antimicrobial regimen considering the patient's allergy profile.
Ciprofloxacin and metronidazole are selected to cover enteric Gram-negative bacilli and anaerobes.
The patient has a history of penicillin-induced anaphylaxis, making primary beta-lactam options like piperacillin-tazobactam strictly contraindicated.
4
Review home medications for potential drug-drug interactions and acute contraindications.
The scheduled dose of warfarin must be withheld.
Metronidazole is a strong CYP2C9 inhibitor that significantly increases warfarin levels. Furthermore, the patient has acute hepatic dysfunction and will likely require an urgent invasive procedure (ERCP), necessitating the cessation of anticoagulation.

Key Concept

Management of septic shock secondary to ascending cholangitis involves aggressive hemodynamic resuscitation, selection of empiric antimicrobials tailored to patient allergies (avoiding beta-lactams in severe IgE-mediated reactions), and critical medication reconciliation (recognizing CYP450 interactions and acute contraindications).
Question 1911Question →

An 84-year-old man is evaluated on postoperative day 4 following a right hip hemiarthroplasty for a femoral neck fracture. His postoperative course has been uncomplicated, and his pain is well-controlled with oral acetaminophen. His past medical history includes hypertension, diet-controlled type 2 diabetes mellitus, and mild osteoarthritis. Vital signs are within normal limits. The surgical incision is clean and intact. Before the fall, the patient lived in a single-story home with his 82-year-old wife, who uses a wheeled walker for mobility. Prior to hospitalization, he ambulated independently. He currently requires maximum assistance for transfers and can only take a few steps with a walker. Physical and occupational therapy evaluate him and note that while he is highly motivated, he fatigues rapidly, participating in only 45 minutes of therapy per session before requiring a prolonged rest. The therapy team recommends continued daily rehabilitation. Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Discharge to a skilled nursing facility

Answer

Discharge to a skilled nursing facility
The correct disposition is a skilled nursing facility. The patient is medically stable and ready for discharge from acute care, but requires continued daily therapy and assistance with mobility. Because his elderly wife relies on a walker, she cannot safely provide the maximum assistance he currently needs for transfers, making a discharge home unsafe. Although he needs daily rehabilitation, his inability to tolerate more than 45 minutes of therapy per session precludes admission to an inpatient rehabilitation facility, which requires patients to tolerate at least 3 hours of therapy per day. A skilled nursing facility provides the appropriate level of skilled nursing, daily subacute rehabilitation (typically 1-2 hours daily), and assistance with activities of daily living.

Step-by-Step Solution

1
Assess the patient's medical stability and continued care needs.
The patient is medically stable, his pain is controlled, and his surgical site is healing. He requires continued daily physical and occupational therapy to regain functional independence.
Determining medical stability differentiates the need for acute care from post-acute care.
2
Evaluate the safety and feasibility of a home discharge.
The patient requires maximum assistance for transfers. His wife uses a walker and cannot safely provide this assistance, making a direct discharge home unsafe.
Social support and functional status dictate whether a patient can safely return to the community.
3
Determine the appropriate institutional post-acute care setting based on the patient's therapy tolerance.
The patient fatigues after 45 minutes of therapy. This disqualifies him from an inpatient rehabilitation facility, which requires tolerance of 3 hours of therapy daily. A skilled nursing facility is the correct choice as it matches his rehabilitation endurance.
Medicare guidelines strictly regulate admission criteria for post-acute care facilities based on therapy requirements and patient endurance.

Key Concept

Disposition to an inpatient rehabilitation facility (IRF) requires the patient to tolerate 3 hours of intensive therapy daily; patients needing rehabilitation who cannot meet this requirement should be referred to a skilled nursing facility (SNF).
Question 1912Question →

A 68-year-old woman is brought to the emergency department reporting sudden, severe pain in her left leg that began 4 hours ago. She has a history of rheumatic mitral stenosis and atrial fibrillation, but she has not taken her prescribed warfarin for the past two weeks. Her temperature is 37.1°C (98.8°F), blood pressure is 142/86 mmHg, and pulse is 110/min and irregularly irregular. Physical examination of the left lower extremity reveals absent popliteal and pedal pulses using a handheld Doppler ultrasound. The left leg is cold, pale, and exhibits livedo reticularis extending up to the mid-thigh. The patient has profound loss of light touch sensation over the foot and is unable to actively dorsiflex her toes. Venous Doppler signals in the left foot are audible. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intravenous heparin and emergent open surgical embolectomy

Answer

Intravenous heparin and emergent open surgical embolectomy
This patient presents with classic signs of acute limb ischemia (ALI) due to an arterial embolus, likely originating from the left atrium secondary to untreated atrial fibrillation. The severity of ALI is clinically staged using the Rutherford classification to guide management. This patient has profound sensory loss and muscle weakness (inability to dorsiflex), which classifies her condition as a Rutherford category IIb (immediately threatened) limb. Her limb is not yet irreversible (category III), as evidenced by the short duration (4 hours), lack of rigor mortis, and presence of audible venous Doppler signals. The standard of care for an immediately threatened limb is immediate systemic anticoagulation with intravenous heparin to prevent clot propagation, followed by emergent surgical revascularization (such as open surgical embolectomy or bypass) to rapidly restore perfusion and salvage the limb.

Step-by-Step Solution

1
Diagnose the clinical syndrome
Acute limb ischemia (ALI) secondary to a thromboembolic event.
Sudden onset of pain, pallor, pulselessness, paresthesias, and paralysis in a patient with atrial fibrillation strongly suggests an arterial embolus.
2
Stratify the severity of ischemia
Rutherford category IIb (immediately threatened limb).
The presence of rest pain, profound sensory loss, and early motor deficits (inability to dorsiflex) indicate impending irreversible tissue loss if not rapidly treated. Audible venous signals confirm it is not yet irreversible (Class III).
3
Determine the appropriate procedural intervention based on severity
Immediate surgical revascularization (open embolectomy) alongside systemic anticoagulation.
For an immediately threatened limb, time is tissue. Slower methods like catheter-directed thrombolysis or delays for advanced imaging will result in irreversible muscle necrosis.

Key Concept

Surgical management of immediately threatened acute limb ischemia
Question 1913Question →

Match each patient's clinical presentation with the most appropriate next step in diagnostic test sequencing.

Click a left item, then click its matching right item

Items

A 58-year-old woman with a history of chronic heartburn who presents with new-onset difficulty swallowing solid foods and an unintentional 4.5-kg (10-lb) weight loss over the past two months.
A 42-year-old man with a high pre-test probability for acute pulmonary embolism who has an estimated glomerular filtration rate of 22 mL/min/1.73 m².
A 65-year-old man with massive hematochezia and a recently normal upper endoscopy who remains hemodynamically unstable (blood pressure 80/50 mm Hg) despite aggressive intravenous fluid resuscitation.
A 28-year-old man presenting with acute onset of a severely painful, swollen, and erythematous right knee with limited range of motion, but no systemic symptoms.

Matches

Show answer & explanation

Answer

The correct pairings align the patient's specific presentation, modifying risk factors, and hemodynamic stability with the most definitive and safe initial diagnostic investigation.
Each matching pair demonstrates the fundamental rules of diagnostic test sequencing: ruling out malignancy directly when alarm symptoms are present, utilizing alternative imaging when contrast is contraindicated, prioritizing angiographic intervention in unstable massive hemorrhage, and immediately ruling out infection in acute joint effusions.

Step-by-Step Solution

1
Analyze each patient's primary symptoms to form an initial differential diagnosis.
Identified esophageal pathology, pulmonary embolism, lower gastrointestinal bleeding, and acute monoarthritis.
Establishing the suspected pathology directs the general category of testing required.
2
Identify patient-specific contraindications or instability markers that modify standard algorithms.
Identified alarm symptoms in the GERD patient, severe chronic kidney disease in the pulmonary embolism patient, and hemodynamic instability in the bleeding patient.
Standard diagnostic pathways must be altered when patients cannot safely undergo the typical first-line test (e.g., contrast imaging in renal failure).
3
Select the test that provides the highest diagnostic yield with the lowest iatrogenic risk for the specific scenario.
Matched endoscopy for alarm symptoms, V/Q scan for renal impairment, angiography for unstable bleeding, and arthrocentesis for acute joint effusion.
This represents the optimal sequencing of tests in clinical patient management.

Key Concept

Guideline-directed diagnostic workup algorithms must be modified appropriately based on patient-specific contraindications, alarm symptoms, and hemodynamic stability.
Estimated Time:1m 30s
Question 1914Question →

A 72-year-old man is evaluated in the hospital on day 4 of an admission for a severe exacerbation of chronic obstructive pulmonary disease (COPD). He originally presented with dyspnea, wheezing, and a productive cough. His home medications include inhaled tiotropium, as-needed albuterol, and warfarin for a mechanical mitral valve (target INR 2.5-3.5). Upon admission, he was started on intravenous methylprednisolone, nebulized ipratropium-albuterol, and oral levofloxacin. Today, his dyspnea has completely resolved, and he is breathing comfortably on room air. He reports no chest pain, palpitations, or signs of bleeding. Vital signs are temperature 37.1°C (98.8°F), pulse 82/min, respirations 14/min, and blood pressure 128/78 mm Hg. Laboratory studies obtained this morning show:

Hemoglobin: 13.5 g/dL
Platelet count: 210,000/mm³
Serum creatinine: 1.1 mg/dL
Prothrombin time (PT): 48 seconds
International normalized ratio (INR): 6.2

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Omit the next dose of warfarin and recheck the international normalized ratio tomorrow

Answer

Omit the next dose of warfarin and recheck the international normalized ratio tomorrow
The patient has a supratherapeutic INR (6.2) without any clinical signs of bleeding. The elevation in INR was likely precipitated by the recent initiation of levofloxacin, which can enhance the anticoagulant effect of warfarin by altering intestinal flora and reducing vitamin K production. According to the American College of Chest Physicians (ACCP) guidelines, for a patient with an INR between 4.5 and 10.0 and no evidence of active bleeding, the most appropriate management is to simply withhold the next 1 to 2 doses of warfarin, monitor the INR closely, and resume therapy at a properly adjusted dose once the INR returns to the therapeutic range. Routine administration of oral or intravenous vitamin K is not recommended in this scenario, as it does not improve clinical outcomes and can cause a prolonged period of subtherapeutic anticoagulation.

Step-by-Step Solution

1
Assess the patient's clinical stability and bleeding status.
The patient is hemodynamically stable, his initial respiratory symptoms have resolved, and he has no signs of active bleeding.
The presence or absence of active bleeding dictates the urgency and aggressiveness of anticoagulation reversal.
2
Interpret the laboratory findings in the context of recent medication changes.
The patient has a supratherapeutic INR of 6.2, likely potentiated by the recent addition of levofloxacin.
Identifying the etiology of the elevated INR helps guide management and prevents future over-anticoagulation once therapeutic levels are re-established.
3
Apply standard treatment guidelines for supratherapeutic INR.
For an INR between 4.5 and 10.0 without evidence of bleeding, the standard recommendation is to hold the next 1 to 2 doses of warfarin.
This strategy allows the INR to naturally decline into the therapeutic range without exposing the patient to the risks associated with exogenous vitamin K or blood product administration.

Key Concept

In an asymptomatic patient taking warfarin who develops a supratherapeutic INR between 4.5 and 10.0 without active bleeding, the appropriate management is to withhold the next 1 to 2 doses of warfarin, monitor closely, and avoid routine administration of vitamin K or fresh frozen plasma.
Estimated Time:1m 15s
Question 1915Question →

A 62-year-old woman is brought to the emergency department after being found unresponsive by her family. She is diagnosed with a large left middle cerebral artery (MCA) ischemic stroke. She undergoes successful mechanical thrombectomy but is left with right-sided hemiplegia and expressive aphasia. She is expected to make a gradual but significant recovery over the next few months. Arrange the following care settings in the most appropriate chronological sequence for this patient's anticipated recovery and rehabilitation pathway, starting immediately after her acute intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of care settings is: Neuroscience Intensive Care Unit (Neuro-ICU) → Acute Stroke Step-Down Unit → Inpatient Rehabilitation Facility (IRF) → Home with Home Health Services.
The transition of care for a severe ischemic stroke patient follows a structured pathway driven by medical acuity and functional needs. Immediately following mechanical thrombectomy, intensive monitoring in a Neuro-ICU is mandatory to manage blood pressure and monitor for potential hemorrhagic transformation. Once hemodynamically and neurologically stabilized, the patient is transferred to an Acute Stroke Step-Down Unit to complete the etiologic workup and begin early mobilization. For post-acute care, a patient with significant residual deficits (hemiplegia, aphasia) who can tolerate intensive therapy (at least 3 hours a day) is best served by an Inpatient Rehabilitation Facility (IRF). Finally, after achieving sufficient independence and providing caregiver training, the patient transitions to Home with Home Health Services for continued recovery and community reintegration.

Step-by-Step Solution

1
Determine the immediate post-procedure care setting.
Neuroscience Intensive Care Unit (Neuro-ICU).
Patients undergoing mechanical thrombectomy for acute ischemic stroke require continuous hemodynamic monitoring and frequent neurological checks in an ICU setting to manage reperfusion risks and monitor for hemorrhagic transformation.
2
Identify the setting for the remainder of the acute hospitalization.
Acute Stroke Step-Down Unit.
Once stabilized and past the acute risk period for bleeding or edema, the patient transitions to a specialized floor unit for secondary stroke workup, continuous telemetry, and initial rehabilitation assessment.
3
Determine the appropriate post-acute disposition for significant neurologic deficits.
Inpatient Rehabilitation Facility (IRF).
Given her right-sided hemiplegia and aphasia, she requires intensive, multidisciplinary therapy. IRF admission is justified as she needs at least 3 hours of combined therapy daily and requires close medical supervision.
4
Establish the ultimate long-term discharge plan.
Home with Home Health Services.
After maximizing functional gains in the IRF and ensuring family caregivers are properly trained, the patient can safely transition to her home environment, supported by intermittent visiting nurses and home-based therapists.

Key Concept

Progressive care setting transitions for acute stroke patients, based on medical acuity, monitoring requirements, and functional rehabilitation capacity.
Question 1916Question →

Evaluate the following asymptomatic adult patients presenting to a general internal medicine clinic for their annual wellness visits. For each patient profile, identify the single most appropriate, guideline-concordant preventive care intervention to recommend today.

Click a left item, then click its matching right item

Items

An asymptomatic 61-year-old man who accumulated 35 pack-years of tobacco use before ceasing the habit 8 years ago.
A healthy 41-year-old woman with no family history of malignancies presenting for a routine checkup.
A 26-year-old woman whose last preventive gynecologic evaluation was at age 22, at which time all results were normal.
A 67-year-old woman with well-controlled hypertension who is entirely vaccine-naive since childhood.
A 35-year-old man born in 1991 with no history of injection drug use or blood transfusions, establishing care.

Matches

Show answer & explanation

Answer

The 61-year-old former smoker should receive LDCT of the chest. The 41-year-old woman should receive biennial screening mammography. The 26-year-old woman is due for cervical cytology testing alone. The 67-year-old woman should receive a single dose of the 20-valent pneumococcal conjugate immunization. The 35-year-old man requires a one-time Hepatitis C virus antibody assay.
Each patient accurately aligns with a specific, current USPSTF or ACIP age- or risk-based guideline. The former smoker meets the 50-80 age, 20+ pack-year, and <15 years quit criteria for LDCT. The 41-year-old meets the updated >=40 years criteria for mammography. The 26-year-old is past the 3-year interval for cervical cytology. The 67-year-old is >65, requiring pneumococcal vaccination. The 35-year-old requires the universal 18-79 one-time HCV screen.

Step-by-Step Solution

1
Analyze the 61-year-old male's risk profile.
He is between ages 50 and 80, has a >20 pack-year smoking history (35), and quit <15 years ago (8).
This specific combination mandates annual lung cancer screening using LDCT based on USPSTF guidelines.
2
Evaluate the 41-year-old average-risk woman.
She is age 41. Recent USPSTF guideline updates lowered the starting age for breast cancer screening to 40.
Therefore, she is eligible for biennial screening mammography despite having no family history.
3
Assess the 26-year-old woman's cervical screening needs.
She is between 21 and 29 years old, meaning she requires cytology alone every 3 years. Her last test was 4 years ago.
She is overdue for cervical cytology, making it the appropriate next step.
4
Determine immunization needs for the 67-year-old woman.
She is older than 65 and vaccine-naive.
ACIP guidelines recommend pneumococcal vaccination for all adults 65 and older. PCV20 as a single dose is standard for naive patients in this age bracket.
5
Review the 35-year-old man's screening gaps.
He is an adult between 18 and 79 with no prior HCV screening.
USPSTF recommends universal, one-time HCV screening for all adults in this age range.

Key Concept

USPSTF and ACIP Preventive Care Guidelines in Adult Primary Care
Question 1917Question →

An obstetric rapid response team is managing a 34-year-old G3P3 patient who developed massive, life-threatening hemorrhage shortly after the uncomplicated vaginal delivery of a 4.2-kg infant. The placenta delivered intact. Initial evaluation revealed severe uterine atony. Despite vigorous bimanual massage and the administration of intravenous oxytocin, intramuscular methylergonovine, intramuscular carboprost, and rectal misoprostol, the patient continues to experience profuse bleeding. Her current blood pressure is 82/45 mm Hg with a heart rate of 130/min. A massive transfusion protocol has been initiated. Bedside ultrasound shows an empty uterine cavity, and speculum examination reveals no vaginal or cervical lacerations.

Arrange the following procedural and surgical interventions in the most appropriate sequential order for escalating the management of this patient's refractory postpartum hemorrhage, proceeding from the initial next step to the definitive intervention of last resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of interventions escalates from minimally invasive procedures to definitive surgery: (1) Placement of an intrauterine balloon tamponade device, (2) Exploratory laparotomy with placement of uterine compression sutures, (3) Stepwise pelvic devascularization via bilateral uterine artery ligation, and (4) Total peripartum hysterectomy.
The management of postpartum hemorrhage requires a rapid, stepwise escalation algorithm prioritizing the preservation of life and, when possible, fertility. When uterotonic medications and bimanual massage fail, the immediate next appropriate step is intrauterine balloon tamponade, which can be deployed quickly at the bedside to provide internal mechanical pressure. If the patient continues to bleed and requires laparotomy, the first-line surgical intervention for atony is the placement of uterine compression sutures (e.g., B-Lynch), which manually compress the anterior and posterior uterine walls together. If compression is unsuccessful, the surgeon proceeds to pelvic devascularization, most commonly starting with bilateral uterine artery ligation (O'Leary sutures). Finally, if all uterine-sparing measures are exhausted and life-threatening hemorrhage persists, a total peripartum hysterectomy must be performed as the definitive, life-saving measure.

Step-by-Step Solution

1
Evaluate for minimally invasive mechanical control
Intrauterine balloon tamponade
This provides rapid mechanical compression of the uterine cavity and is the standard next step when uterotonics and bimanual massage fail.
2
Escalate to initial uterine-sparing surgical intervention
Laparotomy with uterine compression sutures
When non-surgical mechanical control fails and laparotomy is required, direct mechanical compression via sutures (e.g., B-Lynch) is generally the fastest and most effective initial surgical approach for atony.
3
Proceed to surgical devascularization if bleeding persists
Bilateral uterine artery ligation
If compression sutures fail to arrest the hemorrhage, stepwise ligation of the pelvic vasculature is performed to decrease arterial flow to the uterus.
4
Perform definitive life-saving intervention
Total peripartum hysterectomy
This is the absolute last resort to save the patient's life when all other uterine-sparing interventions have been exhausted and hemorrhage remains uncontrolled.

Key Concept

The surgical and procedural management of refractory postpartum hemorrhage follows a stepwise algorithm escalating from minimally invasive mechanical tamponade to uterine-sparing surgical techniques (compression sutures, then vascular ligation), culminating in definitive hysterectomy.
Question 1918Question →

A 6262-year-old man is evaluated prior to hospital discharge following an admission for acute decompensated heart failure. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 25%25\%. His home medications prior to admission included lisinopril, carvedilol, and furosemide. During the hospital stay, he was appropriately diuresed to euvolemia. The medical team plans to optimize his guideline-directed medical therapy by discontinuing lisinopril, initiating sacubitril-valsartan, and adding spironolactone. His vital signs are currently stable. Laboratory results obtained this morning show a serum potassium of 4.24.2 mEq/L and an estimated glomerular filtration rate (eGFR) of 5555 mL/min/1.73 m 2^2. Which of the following statements regarding the monitoring and modification of this patient's pharmacotherapy are correct? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: A strict 3636-hour washout period is required between the final dose of the ACE inhibitor and the first dose of the angiotensin receptor-neprilysin inhibitor.; A basic metabolic panel must be re-evaluated within 11 to 22 weeks following discharge to assess for renal dysfunction and electrolyte abnormalities.

Answer

The correct statements are that a 36-hour washout period is required between lisinopril and sacubitril-valsartan, and that a basic metabolic panel must be re-evaluated within 1 to 2 weeks of discharge.
The successful and safe implementation of comprehensive guideline-directed medical therapy for HFrEF requires meticulous monitoring. First, when transitioning a patient from an ACE inhibitor (such as lisinopril) to an angiotensin receptor-neprilysin inhibitor (ARNI, such as sacubitril-valsartan), a strict 36-hour washout period is mandatory. Both drugs prevent the breakdown of bradykinin; concurrent use or insufficient clearance can lead to life-threatening angioedema. Second, the simultaneous initiation of an ARNI and a mineralocorticoid receptor antagonist (spironolactone) places the patient at high risk for hyperkalemia and acute kidney injury. Current guidelines mandate re-evaluating renal function and serum potassium within 1 to 2 weeks following initiation or dose adjustments of these medications.

Step-by-Step Solution

1
Identify the patient's new therapeutic regimen and recent medication changes.
The patient is transitioning from lisinopril (an ACE inhibitor) to sacubitril-valsartan (an ARNI) and is starting spironolactone (an MRA).
Recognizing the specific classes of medications is necessary to anticipate adverse effects, drug interactions, and required monitoring parameters.
2
Determine the safety protocols for transitioning to an ARNI.
A strict 36-hour washout period is identified as a necessary step before starting sacubitril-valsartan after an ACE inhibitor.
Both ACE inhibitors and sacubitril increase bradykinin levels. Overlapping their effects poses a severe risk for angioedema.
3
Determine the laboratory monitoring required for the new regimen.
Checking a basic metabolic panel within 1 to 2 weeks is identified as necessary.
Both ARNIs and MRAs independently reduce aldosterone signaling and affect renal hemodynamics, creating a high risk for hyperkalemia and acute kidney injury shortly after initiation.
4
Evaluate the distractors against standard monitoring timelines and assay interferences.
Serial BNP is inaccurate in patients on sacubitril. Potassium levels of 5.8 mEq/L are a contraindication for MRA titration. Echocardiography at 2-3 weeks is premature.
Sacubitril inhibits BNP degradation. Potassium > 5.5 mEq/L requires holding the MRA. Ventricular remodeling takes 3 to 6 months.

Key Concept

Monitoring and transitioning guideline-directed medical therapy in heart failure with reduced ejection fraction (HFrEF).
Estimated Time:1m 30s
Question 1919Question →

An internal medicine physician evaluates a 41-year-old male patient during a routine follow-up visit. The patient reports a 4-day history of profound exhaustion, nausea without vomiting, and noticing his urine has become dark brown. Thirty days prior, he was diagnosed with active pulmonary tuberculosis and commenced on a four-drug regimen consisting of isoniazid, rifampin, pyrazinamide, and ethambutol. He does not consume alcohol and has no prior history of liver disease. Vital signs show a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure of 118/76 mmHg118/76\text{ mmHg}, and heart rate of 82/min82/\text{min}. Physical examination is notable for mild scleral icterus and moderate tenderness to palpation in the right upper abdominal quadrant. No hepatosplenomegaly is appreciated.

Which of the following are the most appropriate immediate steps in the management of this patient? (Select exactly two)

Select all that apply

Show answer & explanation

Answer: Withhold the entire current antituberculous medication regimen; Obtain serum aminotransferases and total bilirubin levels

Answer

The most appropriate immediate steps are to withhold the entire current antituberculous medication regimen and to obtain serum aminotransferases and total bilirubin levels.
This patient is presenting with classic symptoms of drug-induced liver injury (DILI), a well-documented and severe adverse effect of standard first-line antituberculous therapy. When a patient on isoniazid, rifampin, and pyrazinamide develops clinical signs of hepatitis (e.g., jaundice, dark urine, abdominal tenderness, profound fatigue), standard protocol dictates that all potentially hepatotoxic medications must be stopped immediately. Simultaneously, the clinician must measure serum aminotransferases and bilirubin to quantify the severity of the hepatocellular damage. Once the liver enzymes normalize and symptoms resolve, the medications are typically reintroduced sequentially under close biochemical surveillance.

Step-by-Step Solution

1
Analyze the patient's new-onset symptoms in the context of his recent medication history.
The patient has developed dark urine, scleral icterus, right upper quadrant pain, and severe fatigue exactly four weeks after initiating a four-drug regimen for active tuberculosis.
Recognizing the classic clinical presentation of symptomatic drug-induced liver injury (DILI) is essential for prioritizing immediate management.
2
Determine the required modifications to the patient's pharmacotherapy.
The entire antituberculous regimen must be held immediately.
Three of the four standard tuberculosis medications (isoniazid, rifampin, and pyrazinamide) are hepatotoxic. Continuing any of them during symptomatic hepatitis risks progressive liver necrosis.
3
Select the appropriate diagnostic tests to confirm and quantify the suspected adverse effect.
Order serum aminotransferases (AST, ALT) and total bilirubin.
Objective biochemical data is necessary to evaluate the extent of hepatocellular injury, rule out severe synthetic dysfunction, and monitor for resolution before drugs can be safely reintroduced.

Key Concept

Management of antituberculous drug-induced liver injury requires immediate cessation of all potentially offending agents and baseline evaluation of liver biochemical tests before planning sequential drug reintroduction.
Question 1920Question →

A 48-year-old woman is evaluated during a routine health maintenance visit. She has no current medical complaints and feels well. Her surgical history is significant for a total abdominal hysterectomy with bilateral salpingectomy performed three years ago for symptomatic uterine fibroids. Her ovaries were preserved. Review of her medical records shows that her most recent cervical cancer screening, performed four years ago prior to her surgery, revealed atypical squamous cells of undetermined significance (ASC-US) with a negative high-risk human papillomavirus (hrHPV) test. She has no prior history of cervical intraepithelial neoplasia (CIN) 2, CIN 3, or cervical cancer, and she has not undergone any screening tests since her operation. She is in a monogamous relationship and does not smoke. Vital signs and physical examination are unremarkable. Which of the following is the most appropriate next step in screening for this patient?

Show answer & explanation

Answer: Discontinue cervical cancer screening

Answer

Discontinue cervical cancer screening
The correct answer is to discontinue cervical cancer screening. According to USPSTF guidelines, women who have undergone a total hysterectomy (which involves the removal of both the uterus and the cervix) for benign indications should not undergo further screening. The critical caveat is that patients with a history of a high-grade precancerous cervical lesion (CIN 2 or CIN 3) or cervical cancer must continue screening of the vaginal vault for 25 years after treatment. Although this patient had a prior abnormal result (ASC-US), her concurrent negative hrHPV test indicated a very low risk for high-grade dysplasia. Because ASC-US does not qualify as a high-grade precancerous lesion, she meets the criteria for permanent discontinuation of screening.

Step-by-Step Solution

1
Identify the patient's surgical history and prior screening results.
The patient had a total hysterectomy (cervix removed) for benign fibroids. Her last screening showed ASC-US with negative hrHPV.
Surgical history and previous dysplasia history determine the necessity of ongoing cervical/vaginal vault screening.
2
Evaluate the clinical significance of the prior ASC-US result.
ASC-US with a negative hrHPV test is considered a normal/low-risk finding. It does not meet the criteria for a high-grade precancerous lesion (CIN 2 or CIN 3).
Ongoing screening is only indicated if the patient had a documented history of CIN 2, CIN 3, or cervical cancer prior to hysterectomy.
3
Apply the appropriate USPSTF preventive screening guideline.
Since the patient lacks a cervix and has no history of high-grade dysplasia or cancer, cervical/vaginal screening should be discontinued (Grade D recommendation).
To prevent harm from false positives and unnecessary procedures, evidence-based guidelines recommend halting screening in this population.

Key Concept

Cervical cancer screening should be discontinued in women who have undergone a total hysterectomy for benign disease and have no history of high-grade precancerous lesions (CIN 2 or 3) or cervical cancer.
PreviousPage 96 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 96 | Examkin